MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-20-2026
Abbott Laboratories Cash and Cash Equivalents 2011-2026 | ABT
Annual Cash and Cash Equivalents Abbott Laboratories
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.52 B | 7.62 B | 6.9 B | 9.88 B | 9.8 B | 6.84 B | 3.86 B | 3.84 B | 9.41 B | 18.6 B | 5 B | 4.06 B | 3.48 B | 10.8 B | 6.81 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 18.6 B | 3.48 B | 7.7 B |
Quarterly Cash and Cash Equivalents Abbott Laboratories
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.95 B | 6.53 B | 7.56 B | 6.99 B | 6.28 B | 6.71 B | 7.84 B | 9.16 B | 9.88 B | 9.59 B | 8.94 B | 7.68 B | 9.8 B | 9.3 B | 8.66 B | 8.05 B | 6.84 B | 6.84 B | 6.84 B | 6.84 B | 3.86 B | 3.86 B | 3.86 B | 3.86 B | 3.84 B | 3.84 B | 3.84 B | 3.84 B | 9.41 B | 9.41 B | 9.41 B | 9.41 B | 18.6 B | 18.6 B | 18.6 B | 18.6 B | 5 B | 5 B | 5 B | 5 B | 4.06 B | 4.06 B | 4.06 B | 4.06 B | 3.48 B | 3.48 B | 3.48 B | 3.48 B | 10.8 B | 10.8 B | 10.8 B | 10.8 B | 6.81 B | 6.81 B | 6.81 B | 6.81 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 18.6 B | 3.48 B | 7.51 B |
Cash and Cash Equivalents of other stocks in the Medical devices industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Sensus Healthcare
SRTS
|
22.1 M | $ 4.1 | -2.96 % | $ 66.9 M |  USA |
 |
Axonics Modulation Technologies
AXNX
|
239 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
36.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
19.2 M | - | -26.83 % | $ 2.62 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
246 M | $ 9.86 | 3.25 % | $ 759 M | USA |
 |
BioSig Technologies
BSGM
|
142 K | - | 37.08 % | $ 85.7 M | USA |
 |
Allied Healthcare Products
AHPI
|
3.32 M | - | 3.58 % | $ 2.21 M | USA |
 |
Conformis
CFMS
|
48.7 M | - | - | $ 16.4 M | USA |
 |
Delcath Systems
DCTH
|
43.5 M | $ 9.18 | -0.22 % | $ 329 M | USA |
 |
Stryker Corporation
SYK
|
4.01 B | $ 335.31 | 2.37 % | $ 128 B | USA |
 |
Dynatronics Corporation
DYNT
|
326 K | - | 14.99 % | $ 929 K | USA |
 |
Cardiovascular Systems
CSII
|
66.4 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
18.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
57 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
5.28 M | - | -20.74 % | $ 369 K | USA |
 |
TELA Bio
TELA
|
50.8 M | $ 0.71 | 3.13 % | $ 33.3 M | USA |
 |
CONMED Corporation
CNMD
|
40.8 M | $ 36.91 | -0.32 % | $ 1.15 B | USA |
 |
Insulet Corporation
PODD
|
716 M | $ 220.63 | 2.14 % | $ 15.5 B | USA |
 |
Tandem Diabetes Care
TNDM
|
90.6 M | $ 23.46 | -3.32 % | $ 1.6 B | USA |
 |
Electromed
ELMD
|
15.3 M | $ 24.74 | 0.32 % | $ 209 M | USA |
 |
Neovasc
NVCN
|
51.5 M | - | - | $ 111 M |  Canada |
 |
Cytosorbents Corporation
CTSO
|
3.28 M | $ 0.62 | -8.39 % | $ 33.7 M | USA |
 |
Aethlon Medical
AEMD
|
5.5 M | $ 2.37 | 2.22 % | $ 3.7 M | USA |
 |
BIOLASE
BIOL
|
6.57 M | - | -13.19 % | $ 166 K | USA |
 |
Smith & Nephew plc
SNN
|
619 M | $ 32.45 | - | $ 23.8 B |  Britain |
 |
LivaNova PLC
LIVN
|
636 M | $ 64.75 | 2.28 % | $ 3.53 B | Britain |
 |
InspireMD
NSPR
|
8.94 M | $ 1.74 | -0.57 % | $ 112 M |  Israel |
 |
AdaptHealth Corp.
AHCO
|
106 M | $ 11.6 | 1.84 % | $ 1.57 B | USA |
 |
Penumbra
PEN
|
187 M | $ 337.13 | 0.26 % | $ 13.1 B | USA |
 |
MiMedx Group
MDXG
|
166 M | $ 4.08 | -0.49 % | $ 603 M | USA |
 |
Invacare Corporation
IVC
|
58.8 M | - | - | $ 24.7 M | USA |
 |
Viemed Healthcare
VMD
|
13.5 M | $ 9.32 | -0.32 % | $ 363 M | USA |
 |
Myomo
MYO
|
14.1 M | $ 0.69 | -1.61 % | $ 28.9 M | USA |
 |
NanoVibronix
NAOV
|
752 K | - | - | $ 1.08 M | USA |
 |
Varex Imaging Corporation
VREX
|
145 M | $ 10.72 | 0.28 % | $ 444 M | USA |
 |
Vivos Therapeutics
VVOS
|
6.26 M | $ 1.24 | 7.37 % | $ 6.22 M | USA |
 |
Inspire Medical Systems
INSP
|
105 M | $ 51.41 | - | $ 1.51 B | USA |
 |
Pulmonx Corporation
LUNG
|
69.8 M | $ 1.29 | -1.15 % | $ 52.5 M | USA |
 |
Beyond Air
XAIR
|
4.66 M | $ 0.74 | 0.01 % | $ 50.1 M | USA |
 |
Xtant Medical Holdings
XTNT
|
6.2 M | $ 0.57 | 0.85 % | $ 76.2 M | USA |